Kezar Life Sciences Inc. (KZR)
Kezar Life Sciences Statistics
Share Statistics
Kezar Life Sciences has 7.31M shares outstanding. The number of shares has increased by -89.96% in one year.
| Shares Outstanding | 7.31M |
| Shares Change (YoY) | -89.96% |
| Shares Change (QoQ) | 0.13% |
| Owned by Institutions (%) | 5.73% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 827 |
| FTD / Avg. Volume | 3.1% |
Short Selling Information
The latest short interest is 68.13K, so 0.93% of the outstanding shares have been sold short.
| Short Interest | 68.13K |
| Short % of Shares Out | 0.93% |
| Short % of Float | 0.95% |
| Short Ratio (days to cover) | 2.4 |
Valuation Ratios
The PE ratio is -5.85 and the forward PE ratio is -0.59. Kezar Life Sciences's PEG ratio is 0.33.
| PE Ratio | -5.85 |
| Forward PE | -0.59 |
| PS Ratio | 0 |
| Forward PS | 2.5 |
| PB Ratio | 4.19 |
| P/FCF Ratio | -6.6 |
| PEG Ratio | 0.33 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Kezar Life Sciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.76, with a Debt / Equity ratio of 0.09.
| Current Ratio | 6.76 |
| Quick Ratio | 6.76 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | -0.12 |
| Debt / FCF | -0.15 |
| Interest Coverage | 56.88 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,522,472.73 |
| Employee Count | 55 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -94.8% in the last 52 weeks. The beta is 0.61, so Kezar Life Sciences's price volatility has been higher than the market average.
| Beta | 0.61 |
| 52-Week Price Change | -94.8% |
| 50-Day Moving Average | 5.13 |
| 200-Day Moving Average | 21.03 |
| Relative Strength Index (RSI) | 44.34 |
| Average Volume (20 Days) | 26,693 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -90.61M |
| Net Income | -83.74M |
| EBITDA | -90.61M |
| EBIT | -85.33M |
| Earnings Per Share (EPS) | -1.15 |
Balance Sheet
The company has 41.75M in cash and 11.07M in debt, giving a net cash position of 30.68M.
| Cash & Cash Equivalents | 41.75M |
| Total Debt | 11.07M |
| Net Cash | 30.68M |
| Retained Earnings | -434.5M |
| Total Assets | 144.68M |
| Working Capital | 117.16M |
Cash Flow
In the last 12 months, operating cash flow was -74.21M and capital expenditures -29K, giving a free cash flow of -74.24M.
| Operating Cash Flow | -74.21M |
| Capital Expenditures | -29K |
| Free Cash Flow | -74.24M |
| FCF Per Share | -1.02 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KZR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for KZR is $9, which is 102.2% higher than the current price. The consensus rating is "Hold".
| Price Target | $9 |
| Price Target Difference | 102.2% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Oct 30, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Oct 30, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -4.36 |
| Piotroski F-Score | 3 |